We recently published a list of 10 Best Falling Stocks to Invest in Right Now. In this article, we are going to take a look ...

Shares of Novo Nordisk NVO gained 2.8% on Wednesday likely because the analysts at UBS upgraded the company’s rating from “Neutral” to “Buy.” Novo Nordisk markets its semaglutide medicines as Ozempic ...

On Monday, Novo Nordisk A/S (NVO) stock saw a decline, ending the day at $84.62 which represents a decrease of $-1.64 or -1.90% from the prior close of $86.26. The stock opened at $84.42 and touched a ...

UBS analyst upgraded Novo Nordisk (NVO) to Buy from Neutral with a price target of DKK 750, down from DKK 1,100. Novo Nordisk is “well placed” to continue to benefit from the high demand for ...

UBS Group AG Chief Executive Officer Sergio Ermotti said he will keep cutting headcount in the wake of the historic acquisition of Credit Suisse. The Swiss lender seeks to shed another $5.5 ...

Novo Nordisk A/S (NVO) stock saw a modest uptick, ending the day at $86.26 which represents a slight increase of $0.62 or 0.72% from the prior close of $85.64. The stock opened at $87.22 and touched a ...

LONDON (Reuters) - The U.S. Department of Labor granted UBS a waiver the Swiss bank needs to continue managing U.S. retirement plans after a paperwork error had put ...